미국의 원격 치료 모니터링 시장 규모, 점유율, 동향 분석 보고서 : 전개 모드별, 모니터링 유형별, 최종 용도별, 부문 예측(2025-2030년)

U.S. Remote Therapeutic Monitoring Market Growth & Trends:

The U.S. remote therapeutic monitoring market is anticipated to reach USD 969.81 million by 2030 and is anticipated to grow at a CAGR of 17.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing focus on enhanced data analytics and patient care, favorable government policies, and technological advancements in wearables and mobile health devices are some of the factors contributing to market growth.

The increasing burden of chronic diseases such as diabetes, hypertension, heart disease, and chronic respiratory conditions is one of the most significant driver of the remote therapeutic monitoring market. Managing these conditions often requires continuous monitoring, and remote therapeutic monitoring (RTM) allows for real-time tracking of key health metrics. RTM provides a solution to remotely monitor patients' vital signs and therapeutic progress, making it easier to manage chronic conditions, reduce hospital visits, and improve patient outcomes. As the population with chronic diseases continues to grow, the demand for remote monitoring technologies to manage these conditions is also increasing.

Furthermore, governments and health insurers are increasingly acknowledging the significance of remote monitoring technologies in improving healthcare delivery. For instance, the Centers for Medicare & Medicaid Services (CMS) have broadened reimbursement policies for remote therapeutic monitoring services, encompassing device utilization and care coordination for patients with chronic conditions.

Moreover, the transition from fee-for-service models to value-based care is a major factor influencing the remote therapeutic monitoring (RTM) market. In value-based care models, healthcare providers are encouraged to deliver high-quality care while minimizing costs. RTM supports value-based care by allowing healthcare providers to monitor patient health remotely, reduce hospital readmissions, and prevent complications, thereby contributing to market growth. For instance, in January 2025, Smart Pillbox launched the HealthBuddy app to enhance medication adherence for patients. This app supports therapeutic monitoring by providing users with medication reminders and tracking features.

U.S. Remote Therapeutic Monitoring Market Report Highlights:

• Based on deployment mode, the web & cloud-based segment held the largest market share in 2024 and is expected to register growth at the fastest CAGR from 2025 to 2030. This growth can be attributed to its enhanced accessibility, real-time data capabilities, scalability, cost-effectiveness, improved collaboration among providers, and strong security features.
• Based on monitoring type, therapeutic segment dominated the market and accounted for the largest revenue share in 2024, owing its ability to improve patient engagement and adherence, enable real-time monitoring and adjustments, and support data-driven decision-making processes. In addition, therapeutic data helps optimize resource utilization for cost-effectiveness and aligns with value-based care initiatives, which aim to improve overall health outcomes while managing costs efficiently.
• Based on end use, the healthcare providers segment held the largest market share in 2024. Healthcare providers serve as significant end users in the remote therapeutic monitoring market due to their critical role in enhancing patient care through continuous monitoring, improving communication with patients, making data-driven decisions, achieving cost efficiencies, benefiting from regulatory support, ensuring scalability and accessibility of care, integrating with existing systems effectively, and focusing on preventive care strategies.
• Based on end use, the patients & caregivers segment is expected to register growth at the fastest CAGR during the forecast period.
• In December 2024, ElectronRx anounced to launch the purpleDx smartphone app, designed for remote monitoring of lung function in patients with pulmonary diseases. The app enables users to track their respiratory health, providing real-time data to healthcare providers.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Deployment Mode
  • 1.2.2. Monitoring Type Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Remote Therapeutic Monitoring (RTM) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements in Wearables and Mobile Health Devices
    • 3.2.1.2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
    • 3.2.1.3. Growing preference for telemedicine and telehealth solutions
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Data Security and privacy concerns
    • 3.2.2.2. High initial implementation costs
• 3.3. Market Opportunity Analysis
• 3.4. Market Challenges Analysis
• 3.5. U.S. Remote Therapeutic Monitoring (RTM) Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
    • 3.5.2.4. Environmental Landscape
    • 3.5.2.5. Legal Landscape
    • 3.5.2.6. Social Landscape
• 3.6. Case Study
• 3.7. EHR Integrated RTM Solution
• 3.8. Regulatory Framework

Chapter 4. U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment Mode Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Remote Therapeutic Monitoring (RTM) Market Deployment Mode Movement Analysis
• 4.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by Deployment Mode, 2018 to 2030 (USD Million)
• 4.4. Cloud & Web-based
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. On-premise
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Remote Therapeutic Monitoring Market Monitoring Type Movement Analysis
• 5.3. U.S. Remote Therapeutic Monitoring Market Size & Trend Analysis, by Monitoring Type, 2018 to 2030 (USD Million)
• 5.4. Therapeutic Data
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Therapy Medication Adherence
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Therapy Medication Response
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Non-Physiological Data
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Remote Therapeutic Monitoring (RTM) Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Remote Therapeutic Monitoring (RTM) Market End Use Movement Analysis
• 6.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Healthcare Providers
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Hospitals
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Specialty Clinics
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Rehabilitation Centers
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Nursing Homes & Long-Term Care Facilities
    • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Home Healthcare
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Patients & Caregivers
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Payers
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Zimmer Biomet
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Medsien, Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Adhere+ Corporation
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Academy Medtech Ventures
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. CircleLink Health Inc.
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Limber Health, Inc.
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. HealthArc
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Hero Health, Inc.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. IncludeHealth Inc
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Propeller Health (Resmed)
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives